Skip to main content
Quest Diagnostics

A Descriptive Analysis of Patient Activation Resources for Individuals with Advanced Lung Cancer: A Patient-Focused, Multi-Stakeholder Collaboration

AACR 2026

American Association of Cancer Research

San Diego, CA, April 17-22, 2026

Poster presentation: A Descriptive Analysis of Patient Activation Resources for Individuals with Advanced Lung Cancer: A Patient-Focused, Multi-Stakeholder Collaboration

Authors: Loftis J, Brassil K, Ogilvie M, Cheroke J, Loftus V, Phillips R, Wilcox B, Meyers S, Hogea C

Medical Specialty: Oncology

Related content

On-Demand Webinar
KRAS G12C Mutation: An Emerging Biomarker for NSCLC
Publication
Validation of a Blood Test for Multi-Cancer Risk Stratification in a Lung Cancer Screening Cohort
Publication
Passenger Mutations Link Cellular Origin and Transcriptional Identity in Human Lung Adenocarcinomas
Publication
Learning the Cellular Origins Across Cancers Using Single-Cell Chromatin Landscapes
On-Demand Webinar
Early Detection Better Protection - Colorectal Cancer Screening in the Workplace: A Panel Discussion
Audio Podcast
Enhancing Cancer Treatment Decisions With Ultrasensitive MRD Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.